1,1-dichloroethene decreases expression ISO Sox17 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of SOX17 mRNA CTD PMID:26682919 1,2-dichloroethane increases expression ISO Sox17 (Mus musculus) 6480464 ethylene dichloride results in increased expression of SOX17 mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO Sox17 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of SOX17 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO Sox17 (Mus musculus) 6480464 Estradiol results in decreased expression of SOX17 mRNA CTD PMID:25210133 17beta-estradiol multiple interactions ISO Sox17 (Mus musculus) 6480464 ESR1 protein promotes the reaction [Estradiol results in decreased expression of SOX17 mRNA] CTD PMID:25210133 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Sox17 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SOX17 mRNA CTD PMID:19770486 and PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SOX17 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SOX17 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Sox17 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SOX17 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Sox17 (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SOX17 mRNA CTD PMID:25975270 3-methylcholanthrene multiple interactions ISO Sox17 (Mus musculus) 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SOX17 mRNA CTD PMID:23519560 4,4'-diaminodiphenylmethane affects expression ISO Sox17 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane affects the expression of SOX17 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO Sox17 (Mus musculus) 6480464 bisphenol S results in increased expression of SOX17 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO Sox17 (Mus musculus) 6480464 Fenretinide results in increased expression of SOX17 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine decreases methylation ISO SOX17 (Homo sapiens) 6480464 Decitabine results in decreased methylation of SOX17 promoter CTD PMID:18413743 5-aza-2'-deoxycytidine increases expression ISO SOX17 (Homo sapiens) 6480464 Decitabine results in increased expression of SOX17 mRNA and Decitabine results in increased expression of SOX17 protein CTD PMID:18413743 5-bromo-2'-deoxyuridine decreases localization ISO SOX17 (Homo sapiens) 6480464 Bromodeoxyuridine results in decreased localization of SOX17 protein CTD PMID:24154490 5-fluorouracil decreases expression ISO Sox17 (Mus musculus) 6480464 Fluorouracil results in decreased expression of SOX17 protein CTD PMID:21296659 5-fluorouracil decreases expression ISO SOX17 (Homo sapiens) 6480464 Fluorouracil results in decreased expression of SOX17 mRNA CTD PMID:24737281 5-fluorouracil decreases localization ISO SOX17 (Homo sapiens) 6480464 Fluorouracil results in decreased localization of SOX17 protein CTD PMID:24154490 6-aminonicotinamide decreases localization ISO SOX17 (Homo sapiens) 6480464 6-Aminonicotinamide results in decreased localization of SOX17 protein CTD PMID:24154490 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SOX17 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of SOX17 mRNA CTD PMID:31881176 acetic acid decreases expression ISO Sox17 (Mus musculus) 6480464 Acetic Acid results in decreased expression of SOX17 protein CTD PMID:21296659 actinomycin D decreases localization ISO SOX17 (Homo sapiens) 6480464 Dactinomycin results in decreased localization of SOX17 protein CTD PMID:24154490 aflatoxin B1 decreases expression ISO SOX17 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of SOX17 mRNA CTD PMID:22100608 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SOX17 mRNA CTD PMID:33354967 aflatoxin B1 decreases methylation ISO SOX17 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of SOX17 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO Sox17 (Mus musculus) 6480464 Tretinoin results in increased expression of SOX17 mRNA CTD PMID:16236135 all-trans-retinoic acid affects expression ISO SOX17 (Homo sapiens) 6480464 Tretinoin affects the expression of SOX17 mRNA CTD PMID:31600526 all-trans-retinoic acid multiple interactions ISO SOX17 (Homo sapiens) 6480464 [4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Tretinoin] inhibits the reaction [Chir 99021 results in increased expression of SOX17 mRNA] CTD PMID:31711903 all-trans-retinoic acid decreases localization ISO SOX17 (Homo sapiens) 6480464 Tretinoin results in decreased localization of SOX17 protein CTD PMID:24154490 all-trans-retinol multiple interactions ISO Sox17 (Mus musculus) 6480464 [Vitamin A co-treated with INHBA protein] results in increased expression of SOX17 mRNA CTD PMID:17244017 angiotensin II increases expression ISO SOX17 (Homo sapiens) 329853320 Angiotensin II increases expression of SOX17 mRNA and protein in retinal microvascular endothelial cells RGD angiotensin II decreases expression ISO SOX17 (Homo sapiens) 329853329 Angiotensin II decreases expression of SOX17 protein in retinal endothelial cells RGD Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of SOX17 mRNA CTD PMID:34858468 arsenite(3-) increases methylation ISO SOX17 (Homo sapiens) 6480464 arsenite results in increased methylation of SOX17 promoter CTD PMID:23974009 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of SOX17 mRNA CTD PMID:21839799 benzo[a]pyrene increases methylation ISO SOX17 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SOX17 3' UTR and Benzo(a)pyrene results in increased methylation of SOX17 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO Sox17 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA CTD PMID:27858113 benzo[a]pyrene increases expression ISO Sox17 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SOX17 mRNA CTD PMID:19770486 more ... benzo[b]fluoranthene increases expression ISO Sox17 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of SOX17 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO Sox17 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA CTD PMID:27858113 Benzo[k]fluoranthene increases expression ISO Sox17 (Mus musculus) 6480464 benzo(k)fluoranthene results in increased expression of SOX17 mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of SOX17 mRNA CTD PMID:25031359 bisphenol A increases expression ISO Sox17 (Mus musculus) 6480464 bisphenol A results in increased expression of SOX17 mRNA CTD PMID:24090592 and PMID:30951980 bisphenol A increases expression ISO SOX17 (Homo sapiens) 6480464 bisphenol A results in increased expression of SOX17 mRNA CTD PMID:27271280 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SOX17 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SOX17 mRNA CTD PMID:25181051 more ... bisphenol F increases expression ISO Sox17 (Mus musculus) 6480464 bisphenol F results in increased expression of SOX17 mRNA CTD PMID:30951980 bromochloroacetic acid decreases expression ISO Sox17 (Mus musculus) 6480464 bromochloroacetic acid results in decreased expression of SOX17 protein CTD PMID:21296659 buta-1,3-diene decreases expression ISO Sox17 (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of SOX17 mRNA CTD PMID:29038090 butanal increases expression ISO SOX17 (Homo sapiens) 6480464 butyraldehyde results in increased expression of SOX17 mRNA CTD PMID:26079696 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of SOX17 mRNA CTD PMID:19167457 calciol increases expression ISO Sox17 (Mus musculus) 6480464 Cholecalciferol results in increased expression of SOX17 mRNA and Cholecalciferol results in increased expression of SOX17 protein CTD PMID:17170073 camptothecin increases methylation ISO SOX17 (Homo sapiens) 6480464 Camptothecin results in increased methylation of SOX17 gene CTD PMID:30720231 carbamazepine affects expression ISO SOX17 (Homo sapiens) 6480464 Carbamazepine affects the expression of SOX17 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO Sox17 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO SOX17 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SOX17 gene] CTD PMID:28238834 CHIR 99021 multiple interactions ISO SOX17 (Homo sapiens) 6480464 4-(5-benzo(1 more ... CTD PMID:31711903 CHIR 99021 increases expression ISO SOX17 (Homo sapiens) 6480464 Chir 99021 results in increased expression of SOX17 mRNA CTD PMID:31711903 Chlorophacinone decreases localization ISO SOX17 (Homo sapiens) 6480464 chlorophacinone results in decreased localization of SOX17 protein CTD PMID:24154490 chloroprene decreases expression ISO Sox17 (Mus musculus) 6480464 Chloroprene results in decreased expression of SOX17 mRNA CTD PMID:23125180 chlorpyrifos increases expression ISO Sox17 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of SOX17 mRNA CTD PMID:34289071 and PMID:37019170 chrysene multiple interactions ISO Sox17 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA CTD PMID:27858113 columbamine decreases expression ISO SOX17 (Homo sapiens) 6480464 columbamine results in decreased expression of SOX17 mRNA CTD PMID:23124089 Cuprizon affects expression EXP 6480464 Cuprizone affects the expression of SOX17 mRNA CTD PMID:27523638 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of SOX17 mRNA CTD PMID:26577399 diethylstilbestrol increases expression ISO SOX17 (Homo sapiens) 6480464 Diethylstilbestrol results in increased expression of SOX17 mRNA CTD PMID:19371625 diethylstilbestrol decreases localization ISO SOX17 (Homo sapiens) 6480464 Diethylstilbestrol results in decreased localization of SOX17 protein CTD PMID:24154490 dimethyl sulfoxide decreases expression ISO SOX17 (Homo sapiens) 6480464 Dimethyl Sulfoxide results in decreased expression of SOX17 mRNA CTD PMID:22105179 diniconazole decreases localization ISO SOX17 (Homo sapiens) 6480464 diniconazole results in decreased localization of SOX17 protein CTD PMID:24154490 dinoseb decreases localization ISO SOX17 (Homo sapiens) 6480464 dinoseb results in decreased localization of SOX17 protein CTD PMID:24154490 diquat decreases localization ISO SOX17 (Homo sapiens) 6480464 Diquat results in decreased localization of SOX17 protein CTD PMID:24154490 dorsomorphin decreases localization ISO SOX17 (Homo sapiens) 6480464 dorsomorphin results in decreased localization of SOX17 protein CTD PMID:24154490 dorsomorphin multiple interactions ISO SOX17 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOX17 mRNA CTD PMID:27188386 doxorubicin decreases localization ISO SOX17 (Homo sapiens) 6480464 Doxorubicin results in decreased localization of SOX17 protein CTD PMID:24154490 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SOX17 mRNA CTD PMID:29391264 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of SOX17 mRNA CTD PMID:30307764 fluazinam decreases localization ISO SOX17 (Homo sapiens) 6480464 fluazinam results in decreased localization of SOX17 protein CTD PMID:24154490 flusilazole decreases localization ISO SOX17 (Homo sapiens) 6480464 flusilazole results in decreased localization of SOX17 protein CTD PMID:24154490 folic acid decreases expression ISO Sox17 (Mus musculus) 6480464 Folic Acid results in decreased expression of SOX17 mRNA CTD PMID:25629700 gefitinib decreases localization ISO SOX17 (Homo sapiens) 6480464 gefitinib results in decreased localization of SOX17 protein CTD PMID:24154490 genistein multiple interactions EXP 6480464 [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of SOX17 mRNA CTD PMID:25031359 genistein decreases expression ISO Sox17 (Mus musculus) 6480464 Genistein results in decreased expression of SOX17 mRNA and Genistein results in decreased expression of SOX17 protein CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SOX17 mRNA CTD PMID:33387578 hexaconazole decreases localization ISO SOX17 (Homo sapiens) 6480464 hexaconazole results in decreased localization of SOX17 protein CTD PMID:24154490 Indeno[1,2,3-cd]pyrene decreases expression ISO Sox17 (Mus musculus) 6480464 indeno(1 more ... CTD PMID:26377693 isoprenaline increases expression ISO Sox17 (Mus musculus) 6480464 Isoproterenol results in increased expression of SOX17 mRNA CTD PMID:20003209 isotretinoin decreases localization ISO SOX17 (Homo sapiens) 6480464 Isotretinoin results in decreased localization of SOX17 protein CTD PMID:24154490 lead(0) decreases expression ISO SOX17 (Homo sapiens) 6480464 Lead results in decreased expression of SOX17 mRNA CTD PMID:37467947 Licochalcone B increases expression ISO SOX17 (Homo sapiens) 6480464 licochalcone B results in increased expression of SOX17 mRNA CTD PMID:33647349 lipopolysaccharide increases expression ISO Sox17 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of SOX17 mRNA CTD PMID:10975854 maleic acid increases expression ISO SOX17 (Homo sapiens) 6480464 maleic acid results in increased expression of SOX17 mRNA CTD PMID:28392987 methamphetamine multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of SOX17 mRNA CTD PMID:19564919 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of SOX17 mRNA CTD PMID:19564919 mianserin decreases localization ISO SOX17 (Homo sapiens) 6480464 Mianserin results in decreased localization of SOX17 protein CTD PMID:24154490 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of SOX17 mRNA CTD PMID:25972201 monocrotaline decreases expression EXP 329853317 Monocrotaline decreases expression of Sox17 protein in the lung RGD N-acetyl-L-cysteine multiple interactions ISO SOX17 (Homo sapiens) 329853329 N-acetyl-cysteine inhibits the reaction [angiotensin II decreases expression of SOX17 protein in retinal endothelial cells] RGD N-nitrosodiethylamine decreases expression ISO SOX17 (Homo sapiens) 6480464 Diethylnitrosamine results in decreased expression of SOX17 mRNA CTD PMID:21527772 naphthalene increases expression ISO Sox17 (Mus musculus) 6480464 naphthalene results in increased expression of SOX17 protein CTD PMID:16239640 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SOX17 mRNA CTD PMID:25729387 ozone multiple interactions ISO Sox17 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of SOX17 mRNA CTD PMID:34911549 paracetamol affects expression ISO Sox17 (Mus musculus) 6480464 Acetaminophen affects the expression of SOX17 mRNA CTD PMID:17562736 paracetamol decreases expression ISO SOX17 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SOX17 mRNA CTD PMID:22230336 paraquat increases expression ISO Sox17 (Mus musculus) 6480464 Paraquat results in increased expression of SOX17 mRNA CTD PMID:12595580 perfluorooctane-1-sulfonic acid decreases expression ISO Sox17 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in decreased expression of SOX17 mRNA CTD PMID:25510869 phenobarbital affects expression ISO Sox17 (Mus musculus) 6480464 Phenobarbital affects the expression of SOX17 mRNA CTD PMID:23091169 phenylmercury acetate multiple interactions ISO SOX17 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SOX17 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO Sox17 (Mus musculus) 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of SOX17 mRNA CTD PMID:23519560 remdesivir decreases expression ISO Sox17 (Mus musculus) 6480464 remdesivir results in decreased expression of SOX17 mRNA CTD PMID:35605700 resveratrol decreases expression ISO SOX17 (Homo sapiens) 6480464 resveratrol results in decreased expression of SOX17 mRNA CTD PMID:19371625 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of SOX17 mRNA CTD PMID:25905778 ritanserin decreases localization ISO SOX17 (Homo sapiens) 6480464 Ritanserin results in decreased localization of SOX17 protein CTD PMID:24154490 SB 431542 decreases localization ISO SOX17 (Homo sapiens) 6480464 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in decreased localization of SOX17 protein CTD PMID:24154490 SB 431542 multiple interactions ISO SOX17 (Homo sapiens) 6480464 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:31711903 SCH 23390 multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of SOX17 mRNA CTD PMID:19564919 silicon dioxide decreases expression ISO SOX17 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of SOX17 mRNA CTD PMID:25895662 sorafenib decreases localization ISO SOX17 (Homo sapiens) 6480464 sorafenib results in decreased localization of SOX17 protein CTD PMID:24154490 sunitinib decreases localization ISO SOX17 (Homo sapiens) 6480464 sunitinib results in decreased localization of SOX17 protein CTD PMID:24154490 tetrachloroethene decreases expression ISO Sox17 (Mus musculus) 6480464 Tetrachloroethylene results in decreased expression of SOX17 mRNA CTD PMID:28973375 tetraphene increases expression ISO Sox17 (Mus musculus) 6480464 benz(a)anthracene results in increased expression of SOX17 mRNA CTD PMID:26377693 tetraphene multiple interactions ISO Sox17 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SOX17 mRNA CTD PMID:27858113 thalidomide decreases localization ISO SOX17 (Homo sapiens) 6480464 Thalidomide results in decreased localization of SOX17 protein CTD PMID:24154490 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SOX17 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO Sox17 (Mus musculus) 6480464 titanium dioxide results in increased expression of SOX17 mRNA CTD PMID:23557971 toluene increases expression EXP 6480464 Toluene results in increased expression of SOX17 mRNA CTD PMID:22967744 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of SOX17 mRNA CTD PMID:25729387 trichloroethene decreases methylation EXP 6480464 Trichloroethylene results in decreased methylation of SOX17 gene CTD PMID:27618143 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SOX17 mRNA CTD PMID:33387578 trichloroethene decreases expression ISO Sox17 (Mus musculus) 6480464 Trichloroethylene results in decreased expression of SOX17 mRNA CTD PMID:28013219 triclosan decreases expression ISO SOX17 (Homo sapiens) 6480464 Triclosan results in decreased expression of SOX17 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO Sox17 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of SOX17 mRNA CTD PMID:19042947 valproic acid decreases localization ISO SOX17 (Homo sapiens) 6480464 Valproic Acid results in decreased localization of SOX17 protein CTD PMID:24154490 valproic acid decreases expression ISO SOX17 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of SOX17 mRNA CTD PMID:37505509 valproic acid affects expression ISO SOX17 (Homo sapiens) 6480464 Valproic Acid affects the expression of SOX17 mRNA CTD PMID:25979313 vandetanib decreases localization ISO SOX17 (Homo sapiens) 6480464 vandetanib results in decreased localization of SOX17 protein CTD PMID:24154490 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of SOX17 mRNA CTD PMID:19015723 ziprasidone decreases localization ISO SOX17 (Homo sapiens) 6480464 ziprasidone results in decreased localization of SOX17 protein CTD PMID:24154490 zoledronic acid increases expression ISO SOX17 (Homo sapiens) 6480464 zoledronic acid results in increased expression of SOX17 mRNA CTD PMID:24714768